Weight Loss Injectables

Previously only available for blood sugar control in people with diabetes, weight loss injectables (GLP-1 agonists) are now available in the UK to support weight loss in anyone with a BMI >30, or >27 with certain health conditions.

  • Produced by Novo Nordisk

  • Produced by Eli Lilly

  • Also produced by Novo Nordisk, this is no longer licensed for weight loss and remains only available for blood sugar control in type 2 diabetes.